PALO ALTO, Calif., June 6, 2016 /PRNewswire/ — Eiger BioPharmaceuticals, Inc. announced today plans to participate in the Jefferies 2016 Healthcare Conference in New York City.
David Cory, the President and CEO of Eiger, will present and participate in a question-and-answer session on June 8, 2016 beginning at approximately 2:30 p.m. ET.
A live webcast of the presentation will be available on the Eiger BioPharmaceuticals website at www.eigerbio.com.
A replay of the webcast will be accessible at www.eigerbio.com beginning approximately one hour following the completion of the event.
Eiger is a clinical-stage biopharmaceutical company committed to bringing to market novel products for the treatment of rare diseases. The company has built a diverse portfolio of well-characterized product candidates with the potential to address diseases for which the unmet medical need is high, the biology for treatment is clear, and for which an effective therapy is urgently needed. For additional information about Eiger and its clinical programs, please visit www.eigerbio.com.
SOURCE Eiger Bio, Inc.
Investors: Jim Shaffer, Eiger Bio, Inc., 919-345-4256, firstname.lastname@example.org